FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
FDA regulator accused of using position to exact revenge on old business associate.
Read the full articleYou might also wanna read
AstraZeneca Stock Tumbles 6% Following Late-Stage Heart Disease Drug Trial Failure
AstraZeneca stock fell 9% after its Wainua heart drug trial missed its primary goal, raising questions about management credibility.
AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.
AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.
STAT+: FDA approves Vera Therapeutics kidney disease treatment
The FDA approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune kidney disease.
Experts and former FDA staff call for reforms to FDA's National Priority Voucher program at public hearing
At a hearing, pharma companies and advocates weighed in on the program from former FDA commissioner Makary
cen.acs.org·1mo ago
Cyclic peptides gain pharmaceutical industry momentum as Merck candidate earns FDA priority review
In this Eye on Patents column, we explore the pharmaceutical industry’s embrace of these circular molecules
cen.acs.org·8h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.